Tanja Stüber

1.0k total citations
23 papers, 639 citations indexed

About

Tanja Stüber is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Tanja Stüber has authored 23 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Tanja Stüber's work include Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (6 papers) and HER2/EGFR in Cancer Research (5 papers). Tanja Stüber is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (6 papers) and HER2/EGFR in Cancer Research (5 papers). Tanja Stüber collaborates with scholars based in Germany, Austria and Curacao. Tanja Stüber's co-authors include Achim Wöckel, R. Kreienberg, Frank Edenhofer, Jörg Piontek, Heike Walles, Gerd Krause, Winfried Neuhaus, Antje Appelt‐Menzel, Alevtina Cubukova and Marco Metzger and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Tanja Stüber

21 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanja Stüber Germany 11 315 162 141 124 116 23 639
Jingya Miao United States 13 146 0.5× 180 1.1× 55 0.4× 76 0.6× 66 0.6× 37 566
Saman Sizdahkhani United States 9 124 0.4× 208 1.3× 67 0.5× 169 1.4× 141 1.2× 30 613
Marek Mazurek Poland 12 89 0.3× 230 1.4× 69 0.5× 79 0.6× 128 1.1× 28 592
Na An China 11 164 0.5× 248 1.5× 61 0.4× 40 0.3× 70 0.6× 30 499
Nicholas R. Anderson United States 10 240 0.8× 279 1.7× 54 0.4× 121 1.0× 84 0.7× 26 931
Lars Riedemann Germany 9 140 0.4× 292 1.8× 51 0.4× 43 0.3× 92 0.8× 10 723
Ichiyo Shibahara Japan 19 195 0.6× 255 1.6× 38 0.3× 52 0.4× 181 1.6× 73 1.0k
Seon‐Jin Yoon South Korea 14 162 0.5× 416 2.6× 37 0.3× 82 0.7× 317 2.7× 37 988
Joseph D. DiDomenico United States 13 166 0.5× 168 1.0× 36 0.3× 41 0.3× 59 0.5× 34 566

Countries citing papers authored by Tanja Stüber

Since Specialization
Citations

This map shows the geographic impact of Tanja Stüber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Stüber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Stüber more than expected).

Fields of papers citing papers by Tanja Stüber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Stüber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Stüber. The network helps show where Tanja Stüber may publish in the future.

Co-authorship network of co-authors of Tanja Stüber

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Stüber. A scholar is included among the top collaborators of Tanja Stüber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Stüber. Tanja Stüber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wöckel, Achim, R. Kreienberg, Thorsten Kühn, et al.. (2020). To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?. Breast Cancer Research and Treatment. 185(3). 677–684. 2 indexed citations
2.
Stüber, Tanja, Razieh Monjezi, Johanna Kühnemundt, et al.. (2020). Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 8(1). e000676–e000676. 113 indexed citations
3.
Herr, Daniel, Manfred Wischnewsky, Wolfgang Janni, et al.. (2019). Does chemotherapy improve survival in patients with nodal positive luminal A breast cancer? A retrospective Multicenter Study. PLoS ONE. 14(7). e0218434–e0218434. 21 indexed citations
4.
Stein, Roland, Stefan Ebert, Claus Jürgen Scholz, et al.. (2019). Cognate Nonlytic Interactions between CD8+ T Cells and Breast Cancer Cells Induce Cancer Stem Cell–like Properties. Cancer Research. 79(7). 1507–1519. 38 indexed citations
5.
Wöckel, Achim, Ute‐Susann Albert, Wolfgang Janni, et al.. (2018). The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer. Deutsches Ärzteblatt international. 115(18). 316–323. 52 indexed citations
6.
Stüber, Tanja, et al.. (2018). Effect of immunotherapy of triple negative breast cancer with ROR1 CAR T cells in combination with the TGF-ß receptor I kinase inhibitor SD-208.. Journal of Clinical Oncology. 36(15_suppl). e15050–e15050. 2 indexed citations
7.
Stüber, Tanja, Joachim Diessner, Catharina Bartmann, et al.. (2017). Are There Breast Cancer Patients with Node-Negative Small Tumours, Who Do Not Benefit from Adjuvant Systemic Therapy?. Oncology. 92(6). 317–324. 6 indexed citations
8.
Appelt‐Menzel, Antje, Alevtina Cubukova, Katharina Günther, et al.. (2017). Establishment of a Human Blood-Brain Barrier Co-culture Model Mimicking the Neurovascular Unit Using Induced Pluri- and Multipotent Stem Cells. Stem Cell Reports. 8(4). 894–906. 219 indexed citations
9.
10.
Stüber, Tanja, Christine Wulff, & Achim Wöckel. (2017). Diagnostik und Therapie des Vulva- und Vaginalkarzinoms. Der Gynäkologe. 50(8). 621–629.
11.
Diessner, Joachim, Manfred Wischnewsky, Maria Blettner, et al.. (2016). Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study. PLoS ONE. 11(12). e0168730–e0168730. 14 indexed citations
12.
Bartmann, Catharina, Joachim Diessner, Maria Blettner, et al.. (2016). Factors influencing the development of visceral metastasis of breast cancer: A retrospective multi-center study. The Breast. 31. 66–75. 10 indexed citations
13.
Bartmann, Catharina, Manfred Wischnewsky, Tanja Stüber, et al.. (2016). Pattern of metastatic spread and subcategories of breast cancer. Archives of Gynecology and Obstetrics. 295(1). 211–223. 27 indexed citations
14.
16.
Diessner, Joachim, Manfred Wischnewsky, Tanja Stüber, et al.. (2016). Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer. BMC Cancer. 16(1). 307–307. 43 indexed citations
17.
Stüber, Tanja, et al.. (2015). Prevalence and Associated Risk Factors for Obesity During Pregnancy Over Time. Geburtshilfe und Frauenheilkunde. 75(9). 923–928. 31 indexed citations
18.
Wischhusen, Jörg, Tanja Stüber, Catharina Bartmann, et al.. (2015). Guidelines are advantageous, though not essential for improved survival among breast cancer patients. Breast Cancer Research and Treatment. 152(2). 357–366. 9 indexed citations
19.
Stüber, Tanja, et al.. (2015). Prenatal sonographic ultrasound predictors for the outcome in fetal gastroschisis: a retrospective analysis. Archives of Gynecology and Obstetrics. 293(5). 1001–1006. 4 indexed citations
20.
Stüber, Tanja, et al.. (2013). XY gonadal dysgenesis--development of a germ cell tumor: case report.. PubMed. 34(6). 572–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026